1
/
of
1
Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
TRV-035212-01
Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
SKU:TRV-035212-01
Regular price
$145.00
Regular price
Sale price
$145.00
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Recombinant Preferentially Expressed Antigen In Melanoma (PRAME) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
Share
Product specifications
| Alternative Name | MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors |
| Name Synonym | Preferentially Expressed Antigen In Melanoma |
| Uniprot | P78395 |
| Field of Research | Tumor immunity |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB. |
| Organism Species | Homo sapiens (Human) |
| Form | Freeze-dried powder |
| Buffer | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| Tag | N-terminal His and GST Tag |
| Fragment | Asn416~Leu502 |
| Host | E. coli |
| Host or Source | E.coli |
| Source | Prokaryotic expression |
| Expression System | Prokaryotic expression |
| Calculated Molecular Weight | 39.9kDa |
| Observed Molecular Weight | 40kDa |
| Isoelectripoint | 6.2 |
| Subcellular Location | Membrane, Nucleus |
| Purity | > 90% |
| Endotoxin | <1.0EU per 1μg (determined by the LAL method) |